Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.19.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended 6 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Income Statement [Abstract]        
Government contract revenue $ 0 $ 0 $ 30,000 $ 149,625
OPERATING EXPENSES        
Professional fees 762,337 403,044 1,369,915 852,479
Payroll and related expenses 597,526 672,279 1,203,521 1,274,844
General and administrative 342,339 271,631 724,955 466,528
Total operating expenses 1,702,202 1,346,954 3,298,391 2,593,851
OPERATING LOSS (1,702,202) (1,346,954) (3,268,391) (2,444,226)
OTHER EXPENSE        
Interest and other debt expenses 21 55,106 54,106 110,210
Loss on share for warrant exchanges 4,403 0 4,403 0
Loss on debt extinguishment 0 0 447,011 0
Total other expense 4,424 55,106 505,520 110,210
NET LOSS (1,706,626) (1,402,060) (3,773,911) (2,554,436)
LOSS ATTRIBUTABLE TO NONCONTROLLING INTERESTS (1,589) (8,715) (2,450) (14,864)
NET LOSS ATTRIBUTABLE TO AETHLON MEDICAL, INC. $ (1,705,037) $ (1,393,345) $ (3,771,461) $ (2,539,572)
BASIC AND DILUTED LOSS PER COMMON SHARE $ (1.29) $ (1.17) $ (2.91) $ (2.14)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING – BASIC AND DILUTED 1,317,418 1,185,949 1,294,206 1,184,795